| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/07/2009 | EP2010224A2 Method and composition for treating and preventing tumor metastasis in vivo |
| 01/07/2009 | EP2010209A2 Immunogenic wt-1 peptides and methods of use thereof |
| 01/07/2009 | EP2010208A1 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 01/07/2009 | EP2010207A2 Compositions and methods relating to modulation of immune system components |
| 01/07/2009 | EP2010206A1 Cystine-knot fold cytokine |
| 01/07/2009 | EP2010205A2 Methods for increasing the size of animals using needleless delivery constructs |
| 01/07/2009 | EP2010204A2 Inhibition of tumour growth |
| 01/07/2009 | EP2010203A2 Macrocyclic peptides and methods for making and using them |
| 01/07/2009 | EP2010202A2 Novel antibacterial compounds |
| 01/07/2009 | EP2010201A1 Hcv vaccinations |
| 01/07/2009 | EP2010200A2 Use of fungal polysaccharides as pharmaceutical composition or food complements |
| 01/07/2009 | EP2010167A2 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| 01/07/2009 | EP2010155A2 Glucagon-like peptide 1(glp-1) pharmaceutical formulations |
| 01/07/2009 | EP1885386A4 Non-natural chemokine receptor ligands and methods of use thereof |
| 01/07/2009 | EP1740600A4 Intracellular delivery of osteoinductive proteins and peptides |
| 01/07/2009 | EP1629002B1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 01/07/2009 | EP1581790B1 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 01/07/2009 | EP1551868B1 Factor involved in metastasis and uses thereof |
| 01/07/2009 | EP1543032B1 Method for the rational mutagenesis of a/beta t cell receptors and correspondingly mutated mdm2 protein-specific a/beta t-cell receptors |
| 01/07/2009 | EP1536827B1 Use of protein kinase n beta |
| 01/07/2009 | EP1499277B1 Pyy3-36 for the reduction or prevention of obesity |
| 01/07/2009 | EP1478389B1 Treatment for diseases of the eye |
| 01/07/2009 | EP1455840B1 Treatment of human soft tissue sarcoma with adenoviral vector expressing tnf-alpha |
| 01/07/2009 | EP1436756B1 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 01/07/2009 | EP1406641B1 Krill extracts for prevention and/or treatment of cardiovascular diseases |
| 01/07/2009 | EP1333024B1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/07/2009 | EP1311538B1 Inhibitors of hiv replication and method of treatment of hiv infections |
| 01/07/2009 | EP1257290B1 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 01/07/2009 | EP1212423B1 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP1115874B1 Alzheimer's disease secretase |
| 01/07/2009 | EP1103564B1 Cancer antigens based on tumor suppressor gene wt1 product |
| 01/07/2009 | EP1028745B1 Low-dose interferon immunotherapy |
| 01/07/2009 | EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/07/2009 | EP0966537B1 Fasciola hepatica vaccines |
| 01/07/2009 | EP0966298B1 Pharmaceutical compositions for the treatment of the eye |
| 01/07/2009 | EP0787008B1 Thymosin alpha1 in combination with a natural cytokine mixture for the treatment of a cellular immune deficiency |
| 01/07/2009 | EP0759985B1 Transgenic arthritic mice |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN101341169A Fsh mutants |
| 01/07/2009 | CN101341168A Metastin derivatives and use thereof |
| 01/07/2009 | CN101341118A Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 01/07/2009 | CN101340928A Modified proteases that inhibit complement activation |
| 01/07/2009 | CN101340927A Application of TGF-beta1 inhibitory polypeptide on immune response modifier preparation |
| 01/07/2009 | CN101340926A Method of treating myasthenia gravis |
| 01/07/2009 | CN101340925A Means and methods for mediating protein interference |
| 01/07/2009 | CN101340906A Therapeutic agent or therapeutic method for ischemic stroke |
| 01/07/2009 | CN101340893A Intranasal administration of rapid acting insulin |
| 01/07/2009 | CN101338306A Method for treating cell proliferation hyperthyroidism based on anti-SURVIVIN ribozyme |
| 01/07/2009 | CN101338284A Degradation strain capable of high-efficiency degrading bactericide chlorothalonil and use thereof |
| 01/07/2009 | CN101338281A Recombination preparation of dextran sulfate sodium and applications |
| 01/07/2009 | CN101337992A Fusion protein of urokinase type plasminogen activator a chain and melittin and preparation thereof |
| 01/07/2009 | CN101337989A Novel glucagon-like peptide-1(GLP-1) analogues and use thereof |
| 01/07/2009 | CN101337988A New erythrocyte-stimulating factor analogues |
| 01/07/2009 | CN101337987A Anti-cataract target protein |
| 01/07/2009 | CN101337985A Self-assembly short peptides constructed by D type amino acid, use for nano-biomedicine |
| 01/07/2009 | CN101337071A Composition for preparing anti-cataract products |
| 01/07/2009 | CN101337068A Kidney cell protection function of protease inhibitor and use thereof |
| 01/07/2009 | CN101337067A Compound temperature sensitive type in-situ gel nasal-cavity administration preparation for treating osteoporosis |
| 01/07/2009 | CN101337066A Glutathion instant gel for eye |
| 01/07/2009 | CN101337065A Use of MG132 in preparing medicine for synergistic inductive differentiation therapy of leukaemia |
| 01/07/2009 | CN101336926A Anticancer composition loaded with bortezomib and alkyl agent |
| 01/07/2009 | CN101336915A Medicine combination with antitumor activity |
| 01/07/2009 | CN101336894A Anticancer composition containing platinum compound and bortezomib |
| 01/07/2009 | CN101336893A Sustained-released injection containing bortezomib and topology enzyme inhibitor |
| 01/07/2009 | CN100448994C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 01/07/2009 | CN100448985C Educated NKT cells and their uses in the treatment of immune-related disorder |
| 01/07/2009 | CN100448893C Humanized antibodies that recognize beta amyloid peptide |
| 01/07/2009 | CN100448892C Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application |
| 01/07/2009 | CN100448891C Peptides and related molecules that bind to TALL-1 |
| 01/07/2009 | CN100448890C Novel protein and process for producing same |
| 01/07/2009 | CN100448889C Cytotoxic depsipeptides |
| 01/07/2009 | CN100448484C Spray agent for shielding ray in medical use |
| 01/07/2009 | CN100448483C Treatment for diabetes |
| 01/07/2009 | CN100448482C Freeze dried HGF preparations |
| 01/07/2009 | CN100448481C Novel use of xCT protein and its encoding gene |
| 01/07/2009 | CN100448480C Aseptic powder injection used for breasts of cow with mastitis and preparation method thereof |
| 01/07/2009 | CN100448479C Application of compound PSI in preparation of medicine for treating leucocythemia |
| 01/07/2009 | CN100448454C Cancer treatment composition and method using natural plant essential oils |
| 01/06/2009 | US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 01/06/2009 | US7473769 Produced from Polypedilum vanderplanki larvae; introduction of these genes into animal cells successfully conferred desiccation resistance to the cells. |
| 01/06/2009 | US7473765 Cytokine zalpha11 ligand |
| 01/06/2009 | US7473762 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473760 Cyclic peptide compositions for treatment of sexual dysfunction |
| 01/06/2009 | US7473686 Thrombopoietin mimetics |
| 01/06/2009 | US7473682 Angiogenic peptides and uses thereof |
| 01/06/2009 | US7473681 Kahalalide F |
| 01/06/2009 | US7473680 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 01/06/2009 | US7473679 Treatments employing neuronal exocytosis-inhibiting peptides |
| 01/06/2009 | US7473678 Platelet-derived growth factor compositions and methods of use thereof |
| 01/06/2009 | US7473671 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 01/06/2009 | US7473561 Bone morphogenetic protein-2 in the treatment and diagnosis of cancer |
| 01/06/2009 | US7473535 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
| 01/06/2009 | US7473430 Cancer cell targeting gene delivery method |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473423 Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 01/06/2009 | US7473422 Monoclonal antibody which recognizes polypeptide comprising heme binding motif and sequencially related to cytochrome p450 for use in preventing hydroxylation of retinoic acid and treating cell proliferative and skin disorders |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |